# Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy

> **NCT00428207** · NA · TERMINATED · sponsor: **Joslin Diabetes Center** · enrollment: 4 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin Aspart versus Insulin Lispro
- **DRUG:** Insulin Lispro versus Insulin Aspart

## Key facts

- **NCT ID:** NCT00428207
- **Lead sponsor:** Joslin Diabetes Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Treatment differences not detected with 7 point fingerstick monitoring
- **Last updated:** 2017-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00428207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00428207, "Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00428207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*